Agenus (AGEN) Stock Price, Quote, News & History | Benzinga

Agenus Inc (AGEN) Stock Price, Quote, News & History

AGENNASDAQ

Trade with Public

Trade with Public

$7.66

-0.15-1.92%

At close: Aug 28, 5:00 PM EST

$7.66

N/A

After Hours: 5:37 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.98

Close

$7.66

Volume / Avg.

741.16K / 4.08M

Day Range

$7.61 - $8.07

52 Wk Range

2.71 - 8.85

Market Cap

$344.77M

P/E Ratio

2.61

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

13.18%

Days to Cover

3.92

Recent Agenus Inc News

Coty Posts Mixed Q4 Results, Joins Wolfspeed, ATRenew And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

U.S. stock futures mixed, Nasdaq 100 up 0.1%. Coty Inc (COTY) shares down 7.7% after reporting losses in Q4 and exit of Gucci Beauty license.

Avi Kapoor

Why Is Agenus Stock Falling on Tuesday?

Agenus Inc. (AGEN) stock experiences profit-taking on Tuesday after a 111% surge. Discover the latest clinical data and analyst updates.

Kaustubh Bagalkote

Stock Market Today: Dow, S&P 500, Nasdaq 100 Futures Rise on Better-Than-Expected CPI Data—Tower Semiconductor, Twin Vee, JPMorgan In Focus (UPDATED)

U.S. stock futures were mixed on Tuesday, as the Nasdaq 100 index advanced, while the Dow Jones and S&P 500 indices fell.

Rishabh Mishra

Oracle, Twin Vee PowerCats, Agenus, Micron Technology and SanDisk: Why These 5 Stocks Are on Investors' Radars Today

ORCL, VEEE, AGEN, MU, SNDK were among the stocks seen trending on Monday, July 13, 2026.

Shivdeep Dhaliwal

Crude Oil Surges Over 5%; Twin Vee Powercats Shares Jump

US stocks dip, Nasdaq falls 1%. Dow down 0.34%. Energy shares up 2.1%, tech down 1.2%. Micron Tech drops 5%. Commodities mixed. European and Asian markets close mixed.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-98.50M

Investing Cash Flow (TTM)

70.08M

Financing Cash Flow (TTM)

35.75M

Free Cash Flow (TTM)

-98.50M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

7.32M

Analyst Trends and Forecast

2

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$366.74M

PE Ratio (TTM)

2.61

PE Ratio (FWD)

3.82

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.15

PB Ratio (TTM)

-

Earnings Yield % (TTM)

38.33%

Earnings Yield % (FWD)

26.15%

EV / EBITDA (TTM)

2.39

Price / EBITDA (TTM)

1.83

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$4.42

Company Debt

Total Debt

$30.07M

LT Debt

-

LT Debt Issuance (TTM)

$10.00M

LT Debt Repayment (TTM)

-$12.14M

Total Cash

$18.74M

Debt to Equity

-

Issuance of Debt (TTM)

-$2.14M

Repayment of Debt (TTM)

-$12.14M

Key Statistics

Open

$7.98

Close

$7.66

Volume / Avg.

741.16K / 4.08M

Day Range

$7.61 - $8.07

52 Wk Range

2.71 - 8.85

Market Cap

$344.77M

P/E Ratio

2.61

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

13.18%

Days to Cover

3.92

About

Sector

Health Care

Industry

Biotechnology

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activa...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Agenus (AGEN) stock?

A

You can purchase shares of Agenus (NASDAQ:AGEN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Agenus (AGEN) competitors?

A

Other companies in Agenus’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Agenus (AGEN) stock?

A

Agenus has a consensus price target of $14.00.

Q

What is the current price for Agenus (AGEN)?

A

The stock price for Agenus (NASDAQ: AGEN) is $7.66 last updated August 28, 2026 at 5:37 PM EDT.

Q

Does Agenus (AGEN) pay a dividend?

A

There are no upcoming dividends for Agenus.

Q

When is Agenus (NASDAQ:AGEN) reporting earnings?

A

Agenus does not have any upcoming earnings scheduled.

Q

Is Agenus (AGEN) going to split?

A

There is no upcoming split for Agenus.

Q

What sector and industry does Agenus (AGEN) operate in?

A

Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.